What does CUSIP 68752M108 represent in this 13F holders report?

CUSIP 68752M108 is the security identifier for OFIX - Orthofix Medical Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held OFIX - Orthofix Medical Inc. - Common Stock in Q1 2026?

31 institutional investors reported OFIX - Orthofix Medical Inc. - Common Stock for Q1 2026. Use the holders table for investor-level position and value details.

Orthofix Medical Inc. - Common Stock (OFIX)

CUSIP: 68752M108

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock
Shares outstanding: 39,581,465
Total 13F shares: 731,990
Share change: -105,036
Total reported value: $8,395,356
Price per share: $11.47
Number of holders: 31
Value change: -$1,783,292
Number of buys: 15
Number of sells: 14

Quarterly Holders Quick Answers

What is CUSIP 68752M108?
CUSIP 68752M108 identifies OFIX - Orthofix Medical Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 68752M108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OFIX - Orthofix Medical Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Engine Capital Management, LP	13F 3/4/5	Company · 10%+ Owner	11% from 3/4/5	4,252,921	$64,474,282	—	31 Dec 2025	13F 3/4/5
ENGINE CAPITAL, L.P.	13D/G	Engine Capital Management, LP	11%	4,251,671	$60,331,211	+$8,846,670	07 May 2025	13D/G
Juniper Investment Company, LLC	13D/G 13F	Company	9.6%	3,784,617	$57,715,409	+$8,255,328	11 Feb 2026	13D/G 13F
Rubric Capital Management LP	13F	Company	9.4%	3,721,715	$56,421,199	—	31 Dec 2025	13F
PARADIGM CAPITAL MANAGEMENT INC/NY	13F	Company	8.3%	3,304,899	$50,102,269	—	31 Dec 2025	13F
BlackRock, Inc.	13F 13D/G	Company	7.7% from 13D/G	3,139,838	$47,599,943	—	31 Dec 2025	13F 13D/G
ARMISTICE CAPITAL, LLC	13D/G 13F	Company	6.7%	2,648,000	$40,382,000	+$6,283,000	31 Dec 2025	13D/G 13F
VANGUARD GROUP INC	13F	Company	5.8%	2,304,928	$34,942,708	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	3.6%	1,441,267	$21,849,608	—	31 Dec 2025	13F
Philosophy Capital Management LLC	13F	Company	2.6%	1,015,194	$15,390,341	—	31 Dec 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2.4%	949,087	$14,388,756	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.4%	947,189	$14,362,333	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	2.2%	857,690	$13,002,580	—	31 Dec 2025	13F
AYAL Capital Advisors Ltd	13F	Company	1.9%	742,372	$11,254,360	—	31 Dec 2025	13F
Keith Valentine	3/4/5	President & CEO, Director	— class O/S missing	377,741	$5,156,165	—	28 Feb 2023	3/4/5
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.84%	333,805	$5,060,484	—	31 Dec 2025	13F
Nuveen, LLC	13F	Company	0.84%	332,042	$5,033,757	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.81%	318,646	$4,830,674	—	31 Dec 2025	13F
Jon Carl Serbousek	3/4/5	Executive Chairman, Director	— class O/S missing	346,827	$4,734,189	—	03 Apr 2023	3/4/5
Massimo Calafiore	3/4/5	President & CEO, Director	— mixed-class rows	593,415 mixed-class rows	$4,017,962	-$331,188	04 Mar 2026	3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	0.66%	261,386	$3,962,611	—	31 Dec 2025	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.65%	256,094	$3,882,385	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.6%	237,273	$3,597,058	—	31 Dec 2025	13F
GABELLI FUNDS LLC	13F	Company	0.59%	235,303	$3,567,193	—	31 Dec 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.57%	226,590	$3,432,000	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.57%	224,643	$3,405,597	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.53%	211,419	$3,205,112	—	31 Dec 2025	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.51%	202,606	$3,071,507	—	31 Dec 2025	13F
Kimberley A. Elting	3/4/5	President, Global Orthopedics	— mixed-class rows	271,614 mixed-class rows	$3,056,365	—	08 Jun 2024	3/4/5
Russell Investments Group, Ltd.	13F	Company	0.5%	197,930	$3,000,614	—	31 Dec 2025	13F
Stuart Essig	3/4/5	Director	— class O/S missing	205,966	$2,811,436	—	05 Jan 2023	3/4/5
GAMCO INVESTORS, INC. ET AL	13F	Company	0.43%	171,800	$2,604,488	—	31 Dec 2025	13F
GREAT LAKES ADVISORS, LLC	13F	Company	0.39%	154,862	$2,347,708	—	31 Dec 2025	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.37%	144,507	$2,190,726	—	31 Dec 2025	13F
Trexquant Investment LP	13F	Company	0.34%	136,469	$2,068,870	—	31 Dec 2025	13F
Kevin J. Kenny	3/4/5	President of Global Spine	— class O/S missing	145,810	$1,990,307	—	08 Jan 2024	3/4/5
Lucas Vitale	3/4/5	CP&BOO	— mixed-class rows	205,995 mixed-class rows	$1,912,552	-$80,332	17 Mar 2026	3/4/5
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.3%	117,299	$1,778,253	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.29%	113,796	$1,725,155	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.28%	111,622	$1,692,189	—	31 Dec 2025	13F
Catherine M. Burzik	3/4/5	Director	— class O/S missing	112,803	$1,605,187	—	08 Apr 2024	3/4/5
AMERICAN CENTURY COMPANIES INC	13F	Company	0.26%	101,879	$1,544,486	—	31 Dec 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.25%	98,284	$1,489,985	—	31 Dec 2025	13F
Rice Doug	3/4/5	CFO	— class O/S missing	107,679	$1,469,818	—	11 Apr 2022	3/4/5
John J. Bostjancic	3/4/5	CFO	— class O/S missing	99,670	$1,360,496	—	28 Feb 2023	3/4/5
Point72 Asset Management, L.P.	13F	Company	0.22%	88,216	$1,337,355	—	31 Dec 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.22%	86,708	$1,314,493	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.22%	85,227	$1,292,043	—	31 Dec 2025	13F
Engineers Gate Manager LP	13F	Company	0.22%	85,101	$1,290,131	—	31 Dec 2025	13F
HighVista Strategies LLC	13F	Company	0.21%	85,049	$1,289,343	—	31 Dec 2025	13F

Institutional Holders of Orthofix Medical Inc. - Common Stock (OFIX) as of Q1 2026

As of 31 Mar 2026, Orthofix Medical Inc. - Common Stock (OFIX) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 731,990 shares. The largest 10 holders included Nuveen, LLC, UBS Group AG, Bank of New York Mellon Corp, Assenagon Asset Management S.A., Global Strategic Investment Solutions, LLC, Inspire Investing, LLC, KIRR MARBACH & CO LLC /IN/, Counterpoint Mutual Funds LLC, STRS OHIO, and R Squared Ltd. This page lists 31 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

143

Q1 2026 holders

Holder diff

-112

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.